IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Ther a peu tic Classes (% of Sales by Lead ing
5): 60-65%
Dose Forms (% of Sales by Lead ing 5):
75-80%
Prin ci pal Prod ucts:
GLIVEC (antineoplastic other)
NICOTINELL MINT (antismoking prod uct)
SANDOSTATIN LAR (hor mone hy po tha lamic)
DIOVAN (an gio ten sin-II an tag o nist plain)
NICOTINELL FRUIT (antismoking prod uct)
Ther a peu tic Range:
antineoplastics 20%
CNS drugs other 18%
hor mones pi tu itary and hy po tha lamic 10%
renin-an gio ten sin sys tem agents 7%
na sal prep a ra tions 6%
Lead ing Dose Forms:
coated tab lets 31%
spe cial solid forms 17%
tab lets 11%
vi als 10%
liq uids 9%
SANDOZ
Street Ad dress: Berga Alle 1E, S-254 52
Helsingborg
Tel: +46 42 15 20 65
Fax: +46 42 15 41 01
Home Page: www.sandoz.se
Phar ma ceu ti cal Sales: US$ 12-14 mil lion
Prod ucts (% of Sales by Lead ing 5): 55-60%
Ther a peu tic Classes (% of Sales by Lead ing
5): 85-90%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
ENALAPRIL SANDOZ (ACE in hib i tor plain)
CEFADROXIL SANDOZ (cephalosporin)
CEFTAZIDIM SANDOZ (cephalosporin)
ENALAPRIL COMP SAN (ACE in hib i tor com bi na -
tion)
CEFOTAXIM SANDOZ (cephalosporin)
Ther a peu tic Range:
antibacterials sys temic 38%
renin-an gio ten sin sys tem agents 28%
beta-block ing agents 11%
antimycobacterials 6%
an ti his ta mines sys temic 3%
Lead ing Dose Forms:
tab lets 40%
coated tab lets 32%
vi als 19%
cap sules 7%
liq uids 2%
SANDOZ AB
Street Ad dress: Berga Alle 1E, S-254 52
Helsingborg
Tel: +46 42 15 20 65
Fax: +46 42 15 41 01
Home Page: www.sandoz.se
De scrip tion: Dis trib u tor, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, unbranded, pre scrip -
tion, non-pre scrip tion), hos pi tal pharmaceuticals,
bi o log i cal prod ucts. Es tab lished 2006. 15 phar -
ma ceu ti cal employees in 2008.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 3 (2008)
Con tacts (Pharm): Chair man: Hakan
Josephsson; Com mer cial Op er a tions: Al ex an der
Brising; Mar ket Re search: Al ex an der Brising;
Gen eral Con tact: Hakan Josephsson
Sub sid iary of: Sandoz, Den mark
Phar ma ceu ti cal Sales: US$ 30-35 mil lion
Prod ucts (% of Sales by Lead ing 5): 80-85%
Ther a peu tic Classes (% of Sales by Lead ing
5): 85-90%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
METOPROLOL SANDOZ (beta-blocker agent
plain)
OMEPRAZOL SANDOZ (antiulcerant)
SIMVASTATIN SAND A (cho les terol/triglyceride
reg u lat ing prep a ra tion)
CEFUROXIM SANDOZ (cephalosporin)
ZOLPIDEM SANDOZ (hyp notic/sed a tive)
Ther a peu tic Range:
beta-block ing agents 52%
ant ac ids/antiflatulents/antiulcerants 16%
lipid-reg u lat ing/antiatheroma prep a ra tions
11%
antibacterials sys temic 7%
psycholeptics 3%
Lead ing Dose Forms:
tab lets 58%
coated tab lets 19%
cap sules 16%
vi als 5%
creams 1%
© 2009 IMS Health In cor po rated or its af fil i ates Page 211